Millennium Management’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.91K | Sell |
|
|||||
|
2024
Q4 | $3.59K | Sell |
|
|||||
|
2024
Q3 | $3.19K | Sell |
|
|||||
|
2024
Q2 | $52.4K | Sell |
|
|||||
|
2024
Q1 | $2.24M | Buy |
|
|||||
|
2023
Q4 | $91.8K | Sell |
|
|||||
|
2023
Q3 | $95.8K | Sell |
|
|||||
|
2023
Q2 | $135K | Sell |
|
|||||
|
2023
Q1 | $617K | Sell |
|
|||||
|
2022
Q4 | $2.8M | Buy |
|
|||||
|
2022
Q3 | $202K | Sell |
|
|||||
|
2022
Q2 | $260K | Buy |
|
|||||
|
2022
Q1 | $461K | Sell |
|
|||||
|
2021
Q4 | $996K | Buy |
|
|||||
|
2021
Q3 | $981K | Sell |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|
|||||
|
2021
Q1 | $149K | Sell |
|
|||||
|
2020
Q4 | $837K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $496K | Buy |
|
|||||
|
2020
Q1 | $241K | Buy |
|
|||||
|
2019
Q4 | $414K | Sell |
|
|||||
|
2019
Q3 | $997K | Buy |
|
|||||
|
2019
Q2 | $400K | Buy |
|
|||||
|
2019
Q1 | $228K | Sell |
|
|||||
|
2018
Q4 | $222K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.12M | Sell |
|
|||||
|
2018
Q1 | $3.84M | Buy |
|
|||||
|
2017
Q4 | $221K | Sell |
|
|||||
|
2017
Q3 | $9.58M | Sell |
|
|||||
|
2017
Q2 | $15.4M | Buy |
|
|||||
|
2017
Q1 | $238K | Sell |
|
|||||
|
2016
Q4 | $310K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $115K | Buy |
|